Citigroup
NUTX

Citigroup’s Nutex Health NUTX Stock Holding History

Citigroup’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.3K Buy
687
+412
+150% +$50.5K ﹤0.01% 4426
2025
Q4 		$45.3K Sell
275
-93
-25% -$12.3K ﹤0.01% 4602
2025
Q3 		$38K Sell
368
-1,046
-74% -$103K ﹤0.01% 4573
2025
Q2 		$176K Sell
1,414
-710
-33% -$91.7K ﹤0.01% 4132
2025
Q1 		$99.9K Sell
2,124
-5,762
-73% -$281K ﹤0.01% 4601
2024
Q4 		$250K Buy
7,886
+5,488
+229% +$156K ﹤0.01% 4274
2024
Q3 		$52K Buy
+2,398
New +$34.6K ﹤0.01% 5012
2024
Q2 		– Sell
-5
Closed -$65 – 5718
2024
Q1 		$65 Hold
5
– – ﹤0.01% 5512
2023
Q4 		$127 Hold
5
– – ﹤0.01% 5551
2023
Q3 		$142 Sell
5
-56
-92% -$2.7K ﹤0.01% 5363
2023
Q2 		$3.83K Buy
61
+7
+13% +$600 ﹤0.01% 5213
2023
Q1 		$8.24K Sell
54
-11
-17% -$2.23K ﹤0.01% 4812
2022
Q4 		$18.6K Buy
65
+61
+1,525% +$11.7K ﹤0.01% 4625
2022
Q3 		$1K Sell
4
-10
-71% -$4.24K ﹤0.01% 5657
2022
Q2 		$7K Buy
+14
New +$16.5K ﹤0.01% 5505

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Citigroup's NUTX Position: Q1 2026 in Review

Citigroup increased its Nutex Health (NUTX) stake by 150% in Q1 2026, buying an estimated $50.5K and bringing the position to 687 shares worth $65.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4426.

Citigroup first reported a position in NUTX in Q2 2022 and has held it in 15 quarters since. The position peaked at $250K in Q4 2024. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Citigroup held 687 shares of Nutex Health worth $65.3K as of Q1 2026.
  • Citigroup bought 412 Nutex Health shares in Q1 2026, an estimated $50.5K.
  • Nutex Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4426 holding.
  • Citigroup first reported a position in Nutex Health in Q2 2022 and has held it in 15 quarters since.
  • Citigroup's Nutex Health position peaked at $250K in Q4 2024.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.